Overview
Genomics England partners with the NHS to provide whole genome sequencing for patients with cancer and rare diseases, enabling precise diagnostics and treatment. They offer a secure Research Environment where de-identified genomic and clinical data supports biotech and academic researchers in discovering new therapies. Their bioinformatics tools and platforms drive genomic research, contributing to the UK Life Sciences Vision.
Frequently asked questions
- What genomic services do you provide to the NHS?
- Genomics England provides whole genome sequencing insights for patients with cancer and rare diseases, along with platforms to support accurate diagnosis, effective treatment, and early detection in partnership with the NHS.
- How can researchers access your genomic data?
- Researchers access de-identified genomic and clinical data through the Genomics England Research Environment, a secure platform that enables analysis for new diagnostics and therapies while maintaining patient privacy.
- What are your key focus areas in genomic research?
- Key areas include cancer, rare diseases, newborn sequencing, and diversifying genomic data, with bioinformatics tools to interpret genetic variation and drive personalized medicine.